Smart Money Ratings For 20 Most Undervalued Stocks

Page 4 of 18

15. DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Insider Transaction: 2.49%

Upside Potential: 34.18%

Forward P/E: 7.75

Based in North Carolina, DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is a leading manufacturer of professional dental products and technologies. Its portfolio includes imaging systems, CAD/CAM solutions, consumables, and treatment centers. Serving dental professionals worldwide, the company competes with Align Technology among other players. The focus of the company is on digital dentistry, procedural efficiency, and clinical education to strengthen its brand presence. Its global distribution, combined with intraoral scanning innovations, helps establish a long-term position in dental care.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has climbed 9.91% from its 52-week low, hinting at a recovery. The company achieved organic growth in the first quarter of 2025 in two of its three global regions. Though remaining negative, it surpassed the expectations. Specifically, the company recorded strong performance in the Imaging and Wellspect Healthcare segments, with the help of its new product introductions. Headwinds from global trade tariffs are anticipated to have a $50 million annualized impact. However, DENTSPLY SIRONA Inc. (NASDAQ:XRAY) maintains its 2025 outlook for organic sales and adjusted EPS while raising its sales outlook due to favorable changes in foreign currency translation.

Insider buying at 2.49% reflects moderate internal confidence in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s growth prospects. Hedge funds continue to show interest, with 38 holding positions in the company’s stock. The low forward price-to-earnings ratio of 7.75 signals a potential undervaluation in the stock. Based on analysts’ forecasts, the company has a 34.18% upside potential, acknowledging undervalued fundamentals relative to its earnings potential.

Page 4 of 18